Windtree Therapeutics chairman James Huang resigns, cites value concerns and strategy disagreement

WINDTREE THERAPEUTICS INC /DE/

James Huang resigned as chairman of the board effective April 18, 2023.
Resignation attributed to focus on other pursuits and view that securities did not reflect true value.
Huang criticized strategies that transfer ownership away from existing shareholders.
Resignation letter filed as Exhibit 17.1 with the SEC.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Huang

chairman of the board of directors

WINT · WINDTREE THERAPEUTICS INC /DE/

Effective: 2023-04-18
Filed: April 19, 2023, 7:59 PM ET

On April 18, 2023, Windtree Therapeutics, Inc. (the “ Company ”) received a letter from James Huang announcing his decision to resign from his position as the Company’s chairman of the board of directors, effective immediately (the “ Resignation Letter ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Huang resigned as chairman of the board of directors at WINDTREE THERAPEUTICS INC /DE/.

Action: resigned
Role: chairman of the board of directors

Exact text from the filing

On April 18, 2023, Windtree Therapeutics, Inc. (the “ Company ”) received a letter from James Huang announcing his decision to resign from his position as the Company’s chairman of the board of directors, effective immediately (the “ Resignation Letter ”).

View on SEC.gov

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-23-010586

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.